S. Bolay

1.5k total citations · 1 hit paper
8 papers, 1.2k citations indexed

About

S. Bolay is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, S. Bolay has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Pharmacology and 3 papers in Epidemiology. Recurrent topics in S. Bolay's work include Antifungal resistance and susceptibility (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Fungal Infections and Studies (2 papers). S. Bolay is often cited by papers focused on Antifungal resistance and susceptibility (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Fungal Infections and Studies (2 papers). S. Bolay collaborates with scholars based in Switzerland, United States and Italy. S. Bolay's co-authors include Oscar Marchetti, Thierry Calandra, Andrés Pascual, Thierry Buclin, J. Bille, Laurent A. Décosterd, Jacques Billé, Chantal Csajka, Frédéric Lamoth and Paul Majcherczyk and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Investigative Ophthalmology & Visual Science.

In The Last Decade

S. Bolay

8 papers receiving 1.1k citations

Hit Papers

Voriconazole Therapeutic Drug Monitoring in Patients with... 2007 2026 2013 2019 2007 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Bolay Switzerland 6 878 730 404 161 93 8 1.2k
J. Bille Switzerland 7 1.0k 1.2× 790 1.1× 180 0.4× 121 0.8× 40 0.4× 13 1.1k
Rupali Jain United States 17 412 0.5× 419 0.6× 322 0.8× 25 0.2× 335 3.6× 55 1.1k
Kim M. Strohmaier United States 19 913 1.0× 454 0.6× 133 0.3× 159 1.0× 9 0.1× 28 1.2k
Robert Lupinacci United States 16 2.0k 2.3× 1.7k 2.4× 213 0.5× 82 0.5× 13 0.1× 35 2.4k
David R. Reagan United States 10 733 0.8× 340 0.5× 78 0.2× 28 0.2× 50 0.5× 13 1.1k
J M Vallois France 19 410 0.5× 333 0.5× 404 1.0× 39 0.2× 264 2.8× 36 974
Frank Tverdek United States 15 402 0.5× 358 0.5× 179 0.4× 9 0.1× 182 2.0× 53 765
Michele Wible United States 9 879 1.0× 786 1.1× 243 0.6× 21 0.1× 128 1.4× 18 1.1k
Anette Veringa Netherlands 13 428 0.5× 287 0.4× 190 0.5× 30 0.2× 23 0.2× 17 560
C H Nightingale United States 17 192 0.2× 427 0.6× 657 1.6× 11 0.1× 325 3.5× 37 1.0k

Countries citing papers authored by S. Bolay

Since Specialization
Citations

This map shows the geographic impact of S. Bolay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Bolay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Bolay more than expected).

Fields of papers citing papers by S. Bolay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Bolay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Bolay. The network helps show where S. Bolay may publish in the future.

Co-authorship network of co-authors of S. Bolay

This figure shows the co-authorship network connecting the top 25 collaborators of S. Bolay. A scholar is included among the top collaborators of S. Bolay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Bolay. S. Bolay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Pascual, Andrés, Chantal Csajka, Thierry Buclin, et al.. (2012). Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics–Based Analysis of Adult Patients With Invasive Fungal Infections. Clinical Infectious Diseases. 55(3). 381–390. 163 indexed citations
2.
Giannoni, Éric, Paul Majcherczyk, René Chiolero, et al.. (2010). Prospective monitoring of cefepime in intensive care unit adult patients. Critical Care. 14(2). R51–R51. 85 indexed citations
3.
Lamoth, Frédéric, Thierry Buclin, Andrés Pascual, et al.. (2010). High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile Neutropenic Patients with Mild Impairment of Renal Function. Antimicrobial Agents and Chemotherapy. 54(10). 4360–4367. 137 indexed citations
4.
Bolay, S., et al.. (2007). LodIRO: Helping Linkage Based Eye Research Go Faster. Investigative Ophthalmology & Visual Science. 48(13). 1651–1651. 1 indexed citations
5.
Rochat, Bertrand, S. Bolay, Andrés Pascual, Thierry Calandra, & Oscar Marchetti. (2007). Liquid chromatography‐mass spectrometry method for quantification of caspofungin in clinical plasma samples. Journal of Mass Spectrometry. 42(4). 440–449. 20 indexed citations
6.
Pascual, Andrés, Thierry Calandra, S. Bolay, et al.. (2007). Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes. Clinical Infectious Diseases. 46(2). 201–211. 667 indexed citations breakdown →
7.
Pascual, Andrés, Thierry Calandra, Jacques Billé, et al.. (2006). Variability of Voriconazole Plasma Levels Measured by New High-Performance Liquid Chromatography and Bioassay Methods. Antimicrobial Agents and Chemotherapy. 51(1). 137–143. 82 indexed citations
8.
Bolay, S., et al.. (2003). Blood Flow and ERG Responses to Luminance Flicker in Monkeys. 44(13). 351–351. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026